Wei-Wu He, Director at CASI Pharmaceuticals, Inc. (CASI), bought 241,504 shares at $1.78 ($425K) on 2017-09-19, disclosed to the SEC on 2017-09-20.
Open-market purchase of $425k CASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.75 | 173,500 | $304K | 71.5% |
| 2 | $1.78 | 34,002 | $61K | 14.3% |
| 3 | $1.78 | 34,002 | $61K | 14.3% |
| Total | $1.76 avg | 241,504 | $425K | 100% |
| Filing → |
| CASI | BUY | 2021-08-20 | $614K | — | Filing → |
| CASI | BUY | 2021-03-30 | $12.3M | — | Filing → |
| CASI | BUY | 2020-11-24 | $976K | — | Filing → |